Outcomes
Home » Outcomes


Bancroft NeuroRehab is accredited by CARF International for the following programs:
CARF International outlines areas of strength for Bancroft NeuroRehab:
Net Promoter Score
Net Promoter Score (NPS) is a widely used customer loyalty and satisfaction measurement taken by asking patients how likely they are to recommend Bancroft NeuroRehab to others. Through first-hand feedback, our rehabilitation services rate at an NPS score of 85.06, falling into the Excellent category.


85.06 Excellent
Telehealth Patient Satisfaction:
- On average 100% of participants felt “very satisfied” with the overall quality of the treatment they received through telehealth services.
- The overall all net promoter score was 80% favorable.
- On average 100% of participants were “very satisfied” with the ease of scheduling and the technology they were using for Telehealth.


Testimonials
Patient
Residential Program Family Satisfaction Survey Results:
- 92% felt “very satisfied” with the support they received from staff for their loved one.
- 90% felt “very satisfied” that they were treated with respect and courtesy by all staff members.
- 90% felt their input was considered in developing treatment goals for their loved one.
- 92% felt their group home residence for their loved ones was clean, comfortable and accessible.
- 80% would “highly recommend” Bancroft NeuroRehab residential services.


Patient Success Stories


Jenn’s Story: Reclaiming Life After a Traumatic Brain Injury
For Jennifer Tompkins – life took an unexpected turn. It
About Our Program
Bancroft NeuroRehab helps people in need of neurological rehabilitation live more fulfilling and productive lives through a wide range of therapeutic, vocational, residential and outpatient services. Opened in 1991, Bancroft NeuroRehab is a division of Bancroft, a leading nonprofit service provider for people with neurological disabilities.
Bancroft NeuroRehab therapists treat a wide range of neurological disorders, including traumatic brain injury, concussion, anoxic or hypoxic brain injury, stroke, brain tumor, mild cognitive impairment, Alzheimer’s disease/dementia, multiple sclerosis, and Parkinson’s disease.